JPH09512252A - 呼吸性ウイルス感染の処置における細胞間接着分子／受容体相互作用を遮断する薬剤の使用 - Google Patents

呼吸性ウイルス感染の処置における細胞間接着分子／受容体相互作用を遮断する薬剤の使用

Info

Publication number
JPH09512252A
JPH09512252A JP7526525A JP52652595A JPH09512252A JP H09512252 A JPH09512252 A JP H09512252A JP 7526525 A JP7526525 A JP 7526525A JP 52652595 A JP52652595 A JP 52652595A JP H09512252 A JPH09512252 A JP H09512252A
Authority
JP
Japan
Prior art keywords
icam
antibody
family
use according
glycoproteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7526525A
Other languages
English (en)
Japanese (ja)
Inventor
クレイグ ディー ウェーグナー
アーネスト エル レイモンド
Original Assignee
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド filed Critical ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド
Publication of JPH09512252A publication Critical patent/JPH09512252A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP7526525A 1994-04-12 1995-04-12 呼吸性ウイルス感染の処置における細胞間接着分子／受容体相互作用を遮断する薬剤の使用 Pending JPH09512252A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22599794A 1994-04-12 1994-04-12
US08/225,997 1994-04-12
PCT/US1995/004519 WO1995027736A1 (fr) 1994-04-12 1995-04-12 Utilisation d'agents bloquant l'interaction molecule d'adhesion intercellulaire/recepteur dans le traitement d'une infection respiratoire virale

Publications (1)

Publication Number Publication Date
JPH09512252A true JPH09512252A (ja) 1997-12-09

Family

ID=22847133

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7526525A Pending JPH09512252A (ja) 1994-04-12 1995-04-12 呼吸性ウイルス感染の処置における細胞間接着分子／受容体相互作用を遮断する薬剤の使用

Country Status (4)

Country Link
EP (1) EP0757697A4 (fr)
JP (1) JPH09512252A (fr)
CA (1) CA2187360A1 (fr)
WO (1) WO1995027736A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0362531B1 (fr) 1988-09-01 1999-11-10 Bayer Corporation Protéine du récepteur du rhinovirus humain, qui inhibe le caractère infectieux du virus
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
US5817515A (en) * 1993-12-23 1998-10-06 Icos Corporation Human B2 integrin alpha subunit antibodies
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
JP2007535654A (ja) * 2003-04-23 2007-12-06 ハンサ メディカル アクチボラゲット 抗連鎖球菌物質の確認方法、及び連鎖球菌感染症治療のためのその使用
US12447166B2 (en) * 2016-02-25 2025-10-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
US12594285B2 (en) 2016-02-25 2026-04-07 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
EP3419629A4 (fr) 2016-02-25 2019-10-30 Applied Biological Laboratories, Inc. Compositions et procédés de protection contre des agents pathogènes et des substances irritantes aériens

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE128727T1 (de) * 1987-05-04 1995-10-15 Dana Farber Cancer Inst Inc Interzellulare adhäsions-moleküle und deren bindungsliganden.
ATE114972T1 (de) * 1987-11-02 1994-12-15 Baylor College Medicine Verwendung von icam-1 oder ihre funktionelle derivate zur behandlung unspezifischer entzündungen.
US5235049A (en) * 1989-01-24 1993-08-10 Molecular Therapeutics, Inc. Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1
DK0745852T3 (da) * 1989-03-16 2002-10-14 Blood Res Center Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
WO1993006842A1 (fr) * 1991-10-02 1993-04-15 Boehringer Ingelheim Pharmaceuticals, Inc. Utilisation de molecules d'adhesion intercellulaire et de leurs ligands de liaison dans le traitement de l'asthme

Also Published As

Publication number Publication date
EP0757697A4 (fr) 2000-05-17
CA2187360A1 (fr) 1995-10-19
WO1995027736A1 (fr) 1995-10-19
EP0757697A1 (fr) 1997-02-12

Similar Documents

Publication Publication Date Title
US5324510A (en) Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma
US20110059044A1 (en) Method of treating pulmonary disease with interferons
EP0387701B1 (fr) Utilisation des molécules d'adhésion intercellulaire et leurs ligands de liaison dans le traitement de l'asthme
DK175491B1 (da) Anvendelse af ICAM-1 og dets funktionelle derivater til behandling af ikke-specifik inflammation
CA3118108C (fr) Particules modifiees a modulation immunologique comprenant un acide polylactique
WO1990013316A1 (fr) Dissemination de cellules infectees par l'hiv-1
Lee et al. Cellular immune correlates preventing disease against respiratory syncytial virus by vaccination with virus-like nanoparticles carrying fusion proteins
WO1995027736A1 (fr) Utilisation d'agents bloquant l'interaction molecule d'adhesion intercellulaire/recepteur dans le traitement d'une infection respiratoire virale
EP0868197B1 (fr) Anticorps anti-l-selectine servant a prevenir des defaillances organiques multiples et des lesions organiques aigues
Vincent et al. Intratracheal E. coli lipopolysaccharide induces platelet-dependent bronchial hyperreactivity
US5843441A (en) Use of endothelial-leukocyte adhesion molecule-1 specific antibodies in the treatment of asthma
JP2008508293A (ja) 抗セレクチン剤を用いる感染の治療および予防のための方法
EP1429804B1 (fr) Inhibiteurs de la costimulation par ox40 et leur utilisation contre des immunopathologies inducées par des viruses
WO1993006842A1 (fr) Utilisation de molecules d'adhesion intercellulaire et de leurs ligands de liaison dans le traitement de l'asthme
US20130089551A1 (en) Treatment of pulmonary edema
MXPA96004715A (en) Use of agents that block the molecular interaction / receiver adhesion interaction in the treatment of viral infections respirator
CA2622987C (fr) Methode pour traiter une maladie pulmonaire avec des interferons
US8105571B2 (en) Method of treating pulmonary disease with interferons
JP2001522592A (ja) 遺伝子発現の増大化方法
AU665232B2 (en) Treatment for asthma
Galvao et al. PS-B06-9: SINGLE-CELL TRANSCRIPTOMIC PROFILING OF AORTIC B CELLS DURING EXPERIMENTAL HYPERTENSION
US8771666B2 (en) Ex-vivo treatment of T-cells with IFN-λ
Hartsfield Pulmonary lymphocytes and lung disease in a murine model of AIDS